<DOC>
	<DOC>NCT02160184</DOC>
	<brief_summary>The aim of the study is to assess the efficacy and safety of a closed-loop system consisting of a predictive rule-based algorithm integrated on the Medtronic Portable Glucose Control System (PGCS) in patients with type 1 diabetes for controlling the nocturnal and post-breakfast periods. Intervention will be to apply the automated closed-loop system by administering a subcutaneous insulin microbolus every 5 minutes depending on reading from a continuous glucose measurement (CGM) system.</brief_summary>
	<brief_title>Nocturnal Insulin-Glucose in Hospital: Tight Control</brief_title>
	<detailed_description />
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Type 1 Diabetes Diabetes duration &gt; 3 years Continuous Subcutaneous Insulin Infusion (CSII) treatment for more than 1 year A1c 69% No ketoacidosis during the previous 12 months Glomerular Filtration Rate (GFR) &gt; 60 ml/kg/min m2 Willingness of participate and signed and dated written informed consent in accordance with Good Clinical Practice Gastroparesis Hypoglycemia unawareness Uncorrected visual impairment Deafness BMI&gt; 35 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>